Related Experiment Video
Updated: May 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Mean platelet volume is independently associated with renal dysfunction in stable coronary artery disease
Hakan Uçar1, Mustafa Gür, Nermin Yildiz Koyunsever
1Department of Cardiology, Adana Numune Training and Research Hospital , Adana/Turkey.
Insights
Mean platelet volume (MPV) increases with declining estimated glomerular filtration rate (eGFR) in patients with coronary artery disease. This association may contribute to higher athero-thrombotic risk in those with impaired kidney function.
Area of Science:
- Nephrology
- Cardiology
- Hematology
Background:
- Athero-thrombotic risk increases with declining glomerular filtration rate (GFR).
- Mean platelet volume (MPV) is a risk factor for athero-thrombotic events.
- The relationship between GFR and MPV in stable coronary artery disease (CAD) needs further elucidation.
Purpose of the Study:
- To investigate the association between estimated GFR and MPV in patients with stable CAD.
- To determine if MPV is independently related to eGFR in this population.
Main Methods:
- 471 patients with angiographically proven CAD were included.
- Patients were divided into GFRlow (eGFR <60 ml/min/1.73 m²) and GFRhigh (eGFR ≥60 ml/min/1.73 m²) groups.
- MPV, hs-CRP, and other biochemical markers were measured; eGFR was calculated using the Cockcroft-Gault formula.
Main Results:
- The GFRlow group had higher MPV, hs-CRP, BMI, and prevalence of diabetes, hypertension, and hyperlipidemia.
- Multivariate regression revealed MPV was independently associated with diabetes (β=0.189, p<0.001), eGFR (β=-0.267, p<0.001), hs-CRP (β=0.158, p<0.001), and platelet count (β=-0.116, p=0.002).
Conclusions:
- MPV is independently associated with eGFR, hs-CRP, platelet count, and diabetes in patients with stable CAD.
- These findings suggest a link between impaired renal function and increased athero-thrombotic risk via MPV.
- MPV may serve as a biomarker for assessing athero-thrombotic risk in patients with varying degrees of renal function.
Abstract:
It has been suggested that athero-thrombotic risk progressively increases as the glomerular filtration rate (GFR) declines. Mean platelet volume (MPV) is the most commonly used measure of platelet size, and higher MPV value is independent risk factor for athero-thrombotic disease such as myocardial infarction. We aimed to evaluate the association between estimated GFR and MPV in patients with stable coronary artery disease showing normal to mildly impaired renal function. A total of 471 patients (288 males and 183 females; mean age: 62.5+9.5 years) with angiographically proven CAD were included. The patients were divided into two groups according to the estimated GFR value (GFRlow group: GFR <60 ml/minute per 1.73 m(2) and GFRhigh group: GFR ≥ 60, ml/min per 1.73 m(2)). Estimated GFR was calculated according to the Cockcroft-Gault formula. MPV, high-sensitive C-reactive protein (hsCRP) and other biochemical markers were measured in all patients. Prevalent of CAD was determined by the SYNTAX score. Patients with GFRlow group were of older age, had higher incidence of female gender, current smoker, diabetes, hypertension and hyperlipidemia, lower values of total cholesterol, LDL cholesterol, hemoglobin and platelet count and higher values of BMI, SYNTAX score, hs-CRP and MPV compared with patients with GFRhigh group. Multivariate linear regression analysis showed that the MPV was independently related with diabetes (β=0.189, p<0.001), eGFR (β=-0.267, p<0.001), hs-CRP level (β=0.158, p<0.001) and platelet count (β=-0.116, p=0.002). In conclusion, MPV is independently associated with GFR as well as hsCRP, platelet count and diabetes. These findings may explain, in part, the increase in athero-thrombotic risk with slightly impaired renal function.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Hypertension and Regulation of Blood Pressure
